S100A1 overexpression stimulates cell proliferation and is predictive of poor outcome in ovarian cancer
High levels of <i>S100A1</i> are indicative of adverse clinical outcomes in OC. Our findings suggest that <i>S100A1</i> could serve as a valuable prognostic marker and a potential therapeutic target for OC treatment.
Authors
- Jie Jiang (ORCID: https://orcid.org/0000-0002-9634-4152)
- Jin Wen (ORCID: https://orcid.org/0000-0002-1502-7244)
- Xiaoqian Tuo
- Zhuo Deng (ORCID: https://orcid.org/0000-0002-9884-9509)
- Bin Li (ORCID: https://orcid.org/0000-0002-8607-8874)
- Hui Hui (ORCID: https://orcid.org/0009-0008-6874-0220)
Institutions
- Shanxi Medical University (CN)
- Shanxi Provincial People’s Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tcr-24-430
- Citations
- 2
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Natural Science Foundation of Shaanxi Province